Evogene, Ltd. (EVGN) Return on Sales by Net Profit

Corporate emblem and logo of Evogene, Ltd. (EVGN)

Net profit margins reflect the scaling of AI services for biological system modeling via a SaaS model for Evogene Ltd. (EVGN). The current value is -694.20. Evogene Ltd. (EVGN) utilizes neural networks for drug optimization and plant breeding, securing long-term contracts with industry behemoths. Bioinformatics experts lead these processes, ensuring R&D expenditure transparency and robust intellectual property protection.

Evogene (EVGN) - Net Profitability Margin from 07/04/2022 to 11/19/2026

EVGN (evogene.com): analytical breakdowns and indicator data

- share price and expert price forecast:
Analysis of all company metrics:Evogene Ltd - EVGN
Flagship merchandise of Evogene Ltd.

Evogene Ltd. utilizes artificial intelligence to develop innovative seeds and biologicals, monetizing its technologies through licensing royalties. This indicator reflects the net profit margin, demonstrating the business's resilience to external shocks and demand. Net profit margin analysis allows for tracking the efficiency of converting revenue into final capital. The indicator's extremes reveal historical peaks in operational productivity. This metric is critical for investors to assess the company's ability to maintain profitability amid rising interest rates.